Overview

Study of Creatine Monohydrate in Patients With Amyotrophic Lateral Sclerosis

Status:
Unknown status
Trial end date:
2005-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether nine months of administration of creatine monohydrate results in an increase in muscle strength in patients with amyotrophic lateral sclerosis (ALS).
Phase:
Phase 3
Details
Lead Sponsor:
The Avicena Group